Risk for Bladder Cancer Higher With a History of Urinary Calculi 

Share this content:
Stone formers had nearly double the odds of bladder cancer compared with non-stone-formers, researchers found.
Stone formers had nearly double the odds of bladder cancer compared with non-stone-formers, researchers found.

Having a history of urinary calculi may increase a person's risks for developing bladder cancer, a new meta-analysis suggests.

Based on pooled data from 13 studies, stone formers had nearly 2-fold greater odds of bladder cancer compared with non-stone-formers, Guo Wenbin, MD, of the Third Affiliated Hospital of Southern Medical University in Guangzhou, China, and collaborators reported in Urolithiasis. The odds of bladder cancer were 2-fold higher among patients with a history of bladder stones and 1.4-fold higher among those with a history of kidney stones.

Continue Reading Below

Despite heterogeneity among studies, results held in subgroup analyses by gender, geographic region, and study type. A history of urinary stones was associated with 3-fold greater odds of bladder cancer among women compared with 2-fold greater odds among men.

The odds of bladder cancer among individuals with a history of urinary stones were 1.6-, 1.4-, and 3-fold higher in America, Europe, and Asia, respectively. Analyses of case-control studies and cohort studies also demonstrated increased risks (1.75 and 2.27, respectively).

All told, the findings suggest that a history of urinary calculi is associated with bladder cancer and may impact clinical management and cancer surveillance, Dr Wenbin and colleagues stated. They posited that urinary calculi cause chronic irritation and infections that promote development of neoplastic cells.

In a discussion of study limitations, the investigators noted that important confounders were not evaluated, such as family history, cigarette smoking, body mass index, and occupational exposure to chemicals. In addition, it is possible that bladder cancer was diagnosed more frequently in stone formers due to routine surveillance.

Reference

Yu Z, Yue W, Jiuzhi L, Youtao J, Guofei Z, and Wenbin G. The risk of bladder cancer in patients with urinary calculi: a metaanalysis.  Urolith. doi: 10.1007/s00240-017-1033-7

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs